PoNS™ (ponstherapy.com), short for Portable Neuromodulation Stimulator, is an innovative medical device. It is inclusive of a controller and mouthpiece, that delivers mild stimulation to the surface of the tongue. This stimulation triggers a flow of neural impulses to the brain structures that control balance and gait. PoNS is meant to be used in conjunction with supervised therapeutic activity, referred to as, PoNS Therapy™. Use of the device while engaging in movement and coordination tasks promotes neuromodulation, activating brain pathways to help improve balance and gait.
Helius Medical Technologies, Inc.
Medical Device
Newtown, Pennsylvania 3,117 followers
Visit ponstherapy.com (US) or ponstherapy.ca (Canada) for more information. NASDAQ: HSDT
About us
Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promotes neuroplasticity, aiming to improve the lives of people dealing with neurologic diseases. The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNS). PoNS™, short for Portable Neuromodulation Stimulator, is an innovative medical device. It is inclusive of a controller and mouthpiece, that delivers mild stimulation to the surface of the tongue. This stimulation triggers a flow of neural impulses to the brain structures that control balance and gait. PoNS is meant to be used in conjunction with supervised therapeutic activity, referred to as, PoNS Therapy™. Use of the device while engaging in movement and coordination tasks promotes neuromodulation, activating brain pathways to help improve balance and gait. PoNS is authorized in the United States as a short-term treatment of gait deficit due to mild-to-moderate symptoms from multiple sclerosis (“MS”) and is to be used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only. PoNS is authorized in Canada for three indications: (i) for use as a short-term treatment (14 weeks) of chronic balance deficit due to mild-to-moderate traumatic brain injury (“mmTBI”) and is to be used in conjunction with physical therapy; and (ii) for use as a short-term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from MS and is to be used in conjunction with physical therapy; and (iii) for use as a short-term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from stroke, to be used in conjunction with physical therapy. PoNS is authorized in Australia for short term use by healthcare professionals as an adjunct to a therapeutic exercise program to improve balance and gait.
- Website
-
http://www.heliusmedical.com/
External link for Helius Medical Technologies, Inc.
- Industry
- Medical Device
- Company size
- 11-50 employees
- Headquarters
- Newtown, Pennsylvania
- Type
- Public Company
Locations
-
Primary
Get directions
642 Newtown Yardley Road
Suite 100
Newtown, Pennsylvania 18940, US
Employees at Helius Medical Technologies, Inc.
-
Gerry Huber, PMP, MSMS
Director, Manufacturing, Supply Chain & Logistics at Helius Medical Technologies
-
Patricia Poulin-Ulbricht
Dragonfly Consulting
-
Larry Picciano
Vice President Quality and Regulatory Affairs
-
Bobby Carraway
Commercial and Federal Market Access Consultant, Advising pharmaceutical and medical device clients on business development strategies and…
Updates
-
Individuals who have had a stroke scored higher on the Functional Gait Assessment (FGA), a test that measures walking ability and risk of falling, with PoNS Therapy™ (www.pontherapy.ca) Read more about how PoNS improves your walking and reduces your risk of falling: www.ponstherapy.ca #PoNS #PoNSTherapy #Stroke #StrokeAwareness #GetBackInStepWithLife #StrokeMonth #StrokeSurvivor #FGA
-
-
PoNS™ (www.ponstherapy.ca) is an orally applied therapy that, when combined with physical therapy, improves balance deficit due to mild-to-moderate traumatic brain injury (TBI). Learn more: www.ponstherapy.ca Individual results and experiences may vary. Speak with your physician to see if PoNS is right for you. #PoNS #PoNSTherapy #TraumaticBrainInjury #TBI #mmTBI #BrainInjury #BrainInjuryAwareness #GetBackInStepWithLife #BrainInjurySurvivor #BrainHealth
-
-
When the PoNS® (www.ponstherapy.com) device is used with physical therapy, it improves the walking ability in those with multiple sclerosis to Get Back In Step With Life. Learn more: www.ponstherapy.com Individual results and experiences may vary. Speak to your physician to determine if PoNS is right for you. #PoNS #PoNSTherapy #Helius #PortableNeuromodulationStimulator #physicaltherapy #GetBackInStepWithLife #MultipleSclerosis #MS #PhysicalRehabilitation #Walking
-
-
PoNS® (www.ponstherapy.com) improves the walking ability in those with multiple sclerosis (MS). Just ask our PoNS-users! PoNS Real Stories: https://lnkd.in/eJtHXG_E Here’s what one PoNS user with MS had to say about her PoNS journey: “PoNS Therapy® enabled me to improve my walking. Some tasks seem easier, which makes my daily life better. My walking has improved enough that I rely on walking support devices, like a cane, less often.” Individual results and experiences may vary. Speak to your physician to determine if PoNS is right for you. #PoNS #PoNSTherapy #Helius #PortableNeuromodulationStimulator #physicaltherapy #GetBackInStepWithLife #MultipleSclerosis #MS
-
-
PoNS® (www.ponstherapy.com) is partnering with Lovell® to make PoNS available to Veterans. It is an honor to help those with gait deficit due to multiple sclerosis improve their walking ability. Learn more: https://lnkd.in/eNDqgq8S #PoNS #PoNSTherapy #Helius #PortableNeuromodulationStimulator #physicaltherapy #GetBackInStepWithLife #MultipleSclerosis #MS #PhysicalRehabilitation #Walking #PoNSPulse #BlogPost #Veterans #HonorOurHeroes #VA #USVeterans #Vet #PoNSDevice
-
-
A Pacific Blue Cross initiative alongside the Authorized PoNS Clinic, Surrey Neuroplasticity in Canada, evaluated the real-world impact of PoNS Therapy (ponstherapy.ca) on return-to-work outcomes in individuals on long-term disability due to Traumatic Brain Injury (TBI). • 100% improvement in balance and gait • 89% state balance and gait no longer a barrier to work • 56% of individuals returned to work • PBC estimated that the five individuals who returned to work saved the provider approximately $1.6 million in long-term disability claims To view more details on the study outcomes visit pac.bluecross.ca. To learn more about PoNS Therapy visit ponstherapy.ca. *Individual results and patient experiences may vary.
-
-
We’re #hiring a Managing Director, Canada for the Greater Toronto Area. Know anyone who might be interested?
-
Mobility challenges are prevalent among individuals with neurological disorders, significantly increasing their risk of falls. 46% of these individuals experience one or more falls annually. A recent study in the US published in 2023 estimated the average cost of a fall to be $64.5k. This underscores the urgent need to address falls and mitigate the risk for those with neurological conditions. Enter PoNS (ponstherapy.ca) – a neuromodulation therapy for treating balance and gait deficits and reducing the risk of falls. To learn more about PoNS and the functional outcomes of PoNS Therapy, visit (https://lnkd.in/dkGh9V-J. *Individual results and patient experiences may vary.
-
-
We're excited to share that Helius has received its first third-party insurance reimbursement for PoNS® (www.ponstherapy.com)! This is a step forward in making PoNS® even more accessible. Read the full press release to learn more: https://lnkd.in/em3TebeV #PoNS #PoNSTherapy #CompanyNews #InsuranceReimbursement #HealthcareForAll #PressRelease
-